Uncategorized

The new Scarlet Letter

As employers begin to make plans to bring their employers back, we’ve been reading about many of the new measures they plan to take to keep their workplace and employees safe. Just as employers implemented new security measures after 9/11, the same is being planned now. Workplaces are being redesigned to accommodate social distancing, employers are looking at apps which track and score employees on social distancing, buildings are installing...

It is what it is

We haven’t quite decided yet if the redundancy of these earnings calls is a good thing or not, but as has been said before it is what it is. Novo Nordisk this morning followed this pattern with one exception, and note we did hoop on the call a little late but based on the earnings press release and the presentation they did NOT pull full year financial guidance. This either...

Happy Cinco De Mayo

So here we are Cinco De Mayo which this year falls on Taco Tuesday a holiday we can’t really celebrate because of virus named after a Mexican beer – nope you just can’t make this stuff up. And we thought diabetes was a wacky world. Anyway since we’re on the subject of wackiness consider this; 1. The Three Amigo’s – Dexcom – Insulet and Tandem over the past 30 days are...

The aftermath

As we begin another week some signs are emerging as to what life will look like after this crisis is over. Just this morning J Crew became the first retail causality of the pandemic unfortunately this is first of what we suspect will be many. Last week the unemployment numbers continued to rise another trend we don’t see abating anytime soon. The fact is no one really knows what life...

Tandem Reports

Like everyone else Tandem followed the new pattern when reporting results. They thanked their employees and suppliers, they noted that first quarter results from a pump supply perspective benefited from the crisis as patients stocked up and like everyone, they pulled their full year guidance. Based on their comments they further reinforced what we have been saying since this crisis began, namely as we move forward the second and third...

We should be further along

This morning we were reading an article about Novo Nordisk’s relationship with actor Anthony Anderson, who was diagnosed with Type 2 diabetes over 20 years ago. The actor is currently starring in the TV show “Black-ish” but has appeared on many shows including one of our favorites Law and Order. Anyway on an upcoming episode of Black-ish Novo’s Get Real About Diabetes ad campaign makes an appearance. At the same time...

A pattern emerging

Ok now that we’ve had a few earnings calls a pattern has emerged. First comes the obvious concern over COVID with the compensatory stories about employees going above and beyond their duties. Next comes the we did ok in the first quarter but really have no idea how we’re going to do moving forward therefore we are cancelling any previous guidance we have given and don’t plan on giving any...

The week that was

Not like we need more reasons to call this the wacky world of diabetes but take a look at these items; 1. As trading begins today Dexcom, Insulet and Tandem – the Three Amigos of diabetes tech – are all well off their lows. Dexcom and Insulet have recovered so well both are within spitting distance of their 52 week HIGH. Tandem still has a ways to go to reach that...

Blood Money

In a desperate attempt to stave off bankruptcy Senseonics entered into a new financing agreement yesterday. Per a press release; “Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it has entered into a new senior secured Term Loan Agreement with certain funds managed by Highbridge Capital Management,...

Hold on it’s going to be a rocky ride

Looking at the earnings released by Lilly this morning one just might come away with the impression that Lilly has immunity to the coronavirus and its economic impact. Looking specifically at their diabetes franchise it looks like business as usual. Trulicity, Basaglar and Jardiance all experienced solid growth, while Humalog sales slightly decreased but this had more to do with channel mix/rebates then volume which grew. To some extent we aren’t...